First human test: experimental drug infused for 5 days straight
Knowledge-focused
Completed
This early-stage study tested the safety of an experimental drug called M6229 in 15 healthy volunteers. Participants received the drug through a continuous 120-hour (5-day) IV infusion at different dose levels. The main goal was to check for side effects and understand how the bo…
Phase: PHASE1 • Sponsor: Matisse Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC